MGK, the upcoming trial is for HIV. HIV was not re
Post# of 148285
(Total Views: 478)
Posted On: 03/03/2024 1:41:21 PM
MGK, the upcoming trial is for HIV. HIV was not removed. Ultimately, Leronlimab may be a platform drug treating chronic inflammation across multiple indications. FDA required a HIV trial to come off clinical hold. The trial will target a specific subset of HIV patients.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼